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Available online 29 September 2009Changes in the abundance and properties of blood lipoproteins are generally considered major causes for
varied pathological conditions and diseases. Using novel chromatic biomimetic vesicle and cell assays, we
present here for the ﬁrst time evidence for signiﬁcant changes in lipoproteins' interactions with artiﬁcial
membranes. Speciﬁcally, we demonstrate signiﬁcant differences in membrane binding between lipoproteins
(both low-density lipoprotein [LDL] and high-density lipoprotein [HDL]) harvested from diabetic patients vs.
healthy controls as well as between oxidized and native lipoproteins. The chromatic assays, complemented
by biophysical techniques and electron microscopy, point to signiﬁcant reduction of surface membrane
binding of the lipoproteins as a consequence of diabetes or oxidation. Overall, our results indicate that the
substantial modulation of membrane interactions revealed by the chromatic assays may be used as a new
and potentially powerful marker for screening and prediction of diseases associated with oxidative stress.
© 2009 Elsevier B.V. All rights reserved.1. Introduction
Lipoprotein particles perform the physiologic task of transporting
dietary and endogenously produced lipids [1]. Chylomicrons transport
dietary lipids, while very low-density lipoprotein (VLDL), low-density
lipoprotein (LDL) and high-density lipoprotein (HDL) function to
transport endogenous lipids. VLDL are triglyceride-rich particles,
whereas LDL and HDL function as cholesterol transporters. In humans,
the majority of serum cholesterol is carried by LDL particles. Increased
LDL-cholesterol levels and/or low levels of HDL are associated with
increased risk of cardiovascular disease [2].
Lipoprotein abnormalities are pathological consequences of type
2 diabetes. In particular, dyslipidemia is a common feature in
patients with the disease and is believed to be responsible for the
high risk of complications associated with atherosclerosis in such
patients [3]. Compositional changes in lipoprotein components may-phosphocholine; DMPE, 1,2-
G, 1,2-dimyristoyl-sn-glycero-
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was previously shown that the ratio of esteriﬁed-to-free choles-
terol was increased in LDL particles from diabetic patients, thus
rendering the LDL to increased oxidizability [4]. Many lines of
evidence implicate a major role to the formation of oxidized LDL
(Ox-LDL) in atherosclerosis [5,6], and there is now consensus that
atherosclerosis represents a state of heightened oxidative stress [7].
There is considerable evidence demonstrating that oxidative stress
plays a central role in the pathology of diabetes [8,9], and many
studies have evidenced that Ox-LDL is increased in diabetes [4].
Another characteristic lipid abnormality in diabetic patients is low
HDL levels in plasma. Furthermore, the HDL composition in
diabetes is altered with higher triglycerides. As a result, the
cardioprotective effects of HDL (reverse cholesterol transport and
protection of LDL against oxidation) are signiﬁcantly reduced in
diabetic patients [4].
This study employed newly developed biomimetic chromatic
assays for evaluating the extent of membrane interactions of
lipoproteins. The biomimetic assays are based upon polydiacetylene
(PDA), a lipid-like polymer which exhibits unique colorimetric and
ﬂuorescence properties [10,11]. Speciﬁcally, it has been shown that in
mixed lipid/PDA vesicles [12] or in living cells decorated with PDA
patches fused to the plasma membrane [13], the polymer undergoes
dramatic blue-red and ﬂuorescence transformations induced by
membrane events occurring within the lipid bilayer domains [14].
The chromatic changes of PDA correspond to structural transitions of
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bilayers in the mixed lipid/PDA systems. In essence, many reports
have demonstrated that PDA can serve as a colorimetric and ﬂuo-
rescence reporter of membrane interactions in the lipid/PDA vesicles
and in PDA-labeled cells [12,15]. In this study we questioned whether
application of lipid/PDA assays uncovers dramatic modulation of
membrane binding of native lipoproteins compared to lipoproteins
harvested from diabetic patients or lipoproteins oxidized in vitro.
Here we show that membrane interactions with LDL and HDL, probed
by recently developed biomimetic polymer-based vesicle and cell
assays, are signiﬁcantly affected both in diabetic patients, as well as in
oxidized vs. native lipoproteins.
2. Materials and methods
2.1. Materials
1,2-Dimyristoyl-sn-glycero-3-phosphocholine (DMPC) was
purchased from Avanti (Alabaster, AL), and 1,2-dimyristoyl-sn-
glycero-3-[phospho-rac-(1-glycerol)] (DMPG), 1,2-dimyristoyl-sn-
glycero-3-phospho-ethanolamine (DMPE) and sodium dithionite
were purchased from Sigma. The diacetylenic monomer 10,12-
tricosadiynoic acid (TRCDA) was purchased from Alfa Aesar (Karls-
ruhe, Germany). The powder was washed in chloroform and puriﬁed
through a nylon 0.45 μm ﬁlter (Whatman) before use.
Tris(hydroxymethyl)aminomethane (TRIZMA base buffer,
C4H11NO3) was purchased from Sigma. The ﬂuorescent dyes N-(7-
nitrobenz-2-oxa-1,3-diazol-4-yl)1,2-dihexadecanoyl-sn-glycero-3
phospho-ethanolamine, triethylammonium salt (NBD-PE) and Rho-
damine Red™-X 1,2-dihexadecanoyl-sn-glycero-3-phospho-ethanol-
amine, triethylammonium salt (Rhodamine-DHPE) were purchased
from Molecular Probes (Leiden, Netherlands).
2.2. Human subjects
Ten male patients with type 2 diabetes mellitus, at the age 59±
2 years, with serum glucose levels of 199±33 mg/dL, hemoglobin
A1c levels of 7.5–11.3% and body mass index (BMI) of 30±3 kg/m2,
were included in the study All patients were non-smokers.
Ten healthy volunteers, with plasma cholesterol levels lower than
200 mg/dL, were recruited from the Faculty of Medicine students and
staff. These volunteers were under no drug treatment, non-smokers
and with no metabolic disorders and were included in the study as
controls. Blood was collected from all subjects after 12 h of fast. The
study protocol was approved by the Rambam Helsinki Committee
(No. 3073). Plasma lipid proﬁles of the patients were as follows: LDL-
cholesterol, −83±7 mg/dL; HDL-cholesterol—43±3 mg/dL; trigly-
cerides—183±23 mg/dL.
2.3. Lipoprotein isolation
HDL and LDL were isolated from human plasma samples by
discontinuous density gradient ultracentrifugation [16] and dialyzed
against saline–Na EDTA (1 mmol/L). HDL and LDL protein concen-
tration was determined with the Folin phenol reagent [17].
2.4. Lipoprotein oxidation
For oxidation, HDL and LDL harvested from healthy subjects were
diluted in phosphate-buffered saline (PBS) to 1 mg of protein/mL and
dialyzed overnight against PBS at 4 °C to remove the EDTA. Oxidation
of the lipoproteins was carried out at 37 °C under air in a shaking
water bath. HDL and LDL (1 mg protein/mL) were incubated for 4 h at
37 °C with 35 μmol/L of freshly prepared CuSO4. Oxidation was
terminated by refrigeration at 4 °C. The oxidation extent of Ox-HDL
and Ox-LDL was determined by the TBARS assay [18].2.5. Vesicle preparation
Vesicles containing the diacetylenemonomer 10,12-tricosadiynoic
acid (TRCDA) and the lipid components (DMPC/TRCDA—2:3 mole
ratio, DMPE/DMPG/TRCDA—1:1:3) were dissolved in chloroform/
ethanol (1:1) and dried together in vacuo to constant weight, followed
by addition of deionized water to a ﬁnal concentration of 1 mM and
subsequently probe sonicated at 40 W at 70 °C for 3 min. The vesicle
solution was subsequently cooled at room temperature and kept at
4 °C overnight. The solution was then irradiated at 254 nm for 30 s,
resulting in intense blue color appearance due to polymerization of
the diacetylene units.
Vesicles containing only phospholipids (DMPC, DMPE/DMPG-1:1
mole ratio) were sonicated at 26 W for 10 min at room temperature
and then kept at 4 °C overnight prior to experiments.
2.6. Chromatic cell experiments
Macrophages J-774 were grown in DMEM medium supplemented
with 5% (v/v) heat-inactivated fetal calf serum, 4 mM L-glutamine, 5 μ/
mL penicillin and 50 μg/mL streptomycin in a humidiﬁed 5% CO2
atmosphere at 37 °C.
The cells were seeded on 24-well plates to 90% conﬂuence the day
before the experiment and subsequently washed with HEPES buffer.
The diacetylene/DMPE/DMPG vesicles (ﬁnal lipid concentration of
0.4 mM)were added to the cells in HEPES buffer in 1.5 mL volume and
incubated for 30 min with gentle shaking. Following incubation, the
labeled cells were irradiated for 30 s at 254 nm using a hand-held UV
lamp (UVC-16, Ultra Lum Inc., Claremont, Canada) or a BLX-254 UV-
Crosslinker (Marne La Vallee, France) to achieve polymerization of
PDA. Irradiation resulted in an intense blue appearance of the cell
monolayer. The unbound vesicles were subsequently removed
through careful washing several times, and fresh HEPES buffer was
added before conducting measurements. All experimental steps were
carried out at 25 °C.
2.7. Fluorescence spectroscopy
Fluorescence was measured on a Fluscan Ascent using a 96-well
microplate (grainer), using excitation of 544 nm and emission of
620 nm using LP ﬁlters with normal slits. Using this excitation/
emission pair assured that the background ﬂuorescence of the vesicle
solutions before addition of the lipoproteins was negligible.
Samples for ﬂuorescence measurements were prepared by adding
10 μL lipoprotein solutions to 30 μL of lipid/PDA vesicles followed by
addition of 30 μL 50 mM Tris base buffer (pH 8.0). The samples were
incubated for 30 min at 26 °C prior to measurements. The concentra-
tionsof parent solutionswere 80±20mg/dL (LDL) and130±30mg/dL
(HDL); no experimentally signiﬁcant differences in chromatic
responses were observed within these concentration ranges.
Fluorescent chromatic responses were calculated according to the
formula:
k FCR = EmI = Emred½ 4100k
in which EmI is the value obtained for the vesicle solution after
incubation with lipoproteins, and Emred is the maximal ﬂuorescence
value obtained for the red-phase vesicles (treated with Triton). The
chromatic results reported represent statistical distribution of
multiple measurements of lipoproteins from different patients and
using different vesicle batches.
2.8. Fluorescence quenching
NBD-PE was added to DMPE/DMPG vesicles at a molar ratio of
1:100 (ﬂuorescent dye : phospholipid) and dried together in vacuo
Fig. 1. Chromatic response of lipid/PDA vesicles induced by lipoproteins. (A) Scanned
image of DMPC/PDA vesicles incubated with HDL: (i) control vesicles (no lipoproteins
added); (ii) HDL isolated from healthy controls added; (iii) HDL harvested from
diabetic patients; (iv) HDL oxidized in vitro. (B) A ﬂuorescence dose–response curve for
DMPC/PDA vesicles incubated with HDL harvested from healthy controls.
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by adding 10 μL of the lipoproteins to 30 μL of the vesicles containing
the ﬂuorescent probe and 30 μL of 50 mM Tris base buffer (pH 8.0).
The ﬁnal concentrations obtainedwere 11mg/dL (LDL) and 17mg/dL
(HDL). Measurements were carried out after diluting the sample with
distilled water to a total volume of 1 mL and incubating at 26 °C for
30 min.. The quenching reaction was initiated by adding sodium
dithionite from a stock solution of 0.6 M, prepared in 50 mM Tris base
buffer (pH 11) to a ﬁnal concentration of 1 mM. The decrease in
ﬂuorescence emission was recorded for 7 min at room temperature
using 469 nm excitation and 530 nm emission on an Edinburgh Co.
FL920 spectroﬂuorometer (Edinburgh, Scotland, UK). The ﬂuores-
cence decay curves were calculated as a percentage of the initial
ﬂuorescence measured before the addition of dithionite.
2.9. Fluorescence resonance energy transfer (FRET)
N-(7-Nitro-2,1,3-benzoxadiazol-4-yl)-phosphatidylethanolamine
(N-NBD-PE, ﬂuorescence donor) and N-(lissamine rhodamine B
sulfonyl) phosphatidylethanolamine (N-Rh-PE, ﬂuorescence accep-
tor) were added to DMPE/DMPG vesicles at a molar ratio of 1:1:100
(NBD-PE:Rh-PE:phospholipids) and dried together in vacuo prior to
sonication (see vesicle preparation). Samples were prepared by
adding 30 μL of the lipoproteins to 10 μL of the vesicles containing
the ﬂuorescent probes and 30 μL of 50 mM Tris base buffer (pH 8.0).
Final concentrations were 35 mg/dL (LDL) and 50 mg/dL (HDL).
Fluorescence measurements were carried out after diluting the
samples with distilled water to a total volume of 1 mL and incubating
at 26 °C for 30 min. Fluorescence emission spectra were acquired
(excitation 469 nm) in the range of 500–650 nm on an FL920
spectroﬂuorometer (Edinburgh, UK), using a 1-cm optical path cell.
To measure maximum dispersion of the ﬂuorescent dyes (100%
reduction of FRET), 30 μL of Triton X-100 (t-octylphenoxy polyethox-
yethanol, Sigma) was added to the vesicles [19]. The percentage
decrease of FRET was determined by the equation:
k FRET decrease ¼ ½ðRf − RiÞ= Rt − Rið Þ⁎100
where Rf is the ratio between the emissions at 530 and 590 nm,
respectively, in vesicle solutions incubated with the lipoprotein; Ri is
the ratio for the solution containing only vesicles; and Rt is the ratio
measured in vesicle solutions treated with Triton.
2.10. Confocal ﬂuorescence microscopy
Cell samples for microscopy analysis were prepared according to
the procedure described above (chromatic cell experiments), except
that the cells were seeded on 35-mm glass-bottom MatTek dishes.
Fluorescence images of the PDA-labeled cells were acquired on a
laser-scanning confocal microscope Axiovert-100 M (Zeiss, Germany)
with a Plan-Neoﬂuar 63×/1.2 oil objective. Excitation wavelength
488 nm was produced by an argon laser. Emitted light was passed
through an LP 505 nm ﬁlter.
2.11. Cryogenic transmission electron microscopy (cryo-TEM)
Samples for the cryo-TEM microscopy were prepared in the same
way as for the FRET experiment, above. Four microliters of the sample
to be measured was deposited on perforated polymer ﬁlms supported
on a 300-mesh carbon-coated EM grid (copper, Ted Pella—lacey
substrate). Ultrathin ﬁlms (b300 nm) were formed by removing most
of the solution by blotting. The process was carried out in a
vitriﬁcation system in which the temperature and relative humidity
were controlled, using a Vitrobot (FEI) automatic system. Cryo-TEM
images were recorded on an FEI Tecnai 12 G2 TWIN TEM equipped
with a Gatan 626 cold stage operating at 120 kV.3. Results
3.1. Chromatic vesicle assay
Lipoproteins are known to bind to membrane-embedded recep-
tors, such as the LDL receptor [20]. To evaluate non-speciﬁc binding of
lipoproteins to lipid bilayers, we applied the biomimetic lipid/PDA
vesicle assay (Fig. 1). This simple assay was designed to probe the
extent of membrane binding of tested molecules through induction of
both visible color as well as ﬂuorescence transformations within
chromatic lipid/polymer vesicles [12]. Fig. 1A presents a scanned
image of a multi-well plate containing dimyristoylphosphatydilcho-
line (DMPC)/PDA vesicles (mole ratio 2:3) treated with different HDL
samples (similar results, qualitatively, we recorded in case of LDL, data
not shown).
The colorimetric (blue-red) transitions of PDA-based systems go
hand in hand with induction of ﬂuorescence [21]. Fig. 1B is designed to
explore the correlation between increased concentrations of lipopro-
tein in the tested sample and the chromatic response of the lipid/PDA
vesicles and depicts the ﬂuorescence dose–response curve recorded
following addition of HDL from healthy controls to DMPC/PDA
vesicles. Fig. 1B shows that incubation of the vesicles with elevated
HDL concentrations resulted in higher ﬂuorescence emission; the
direct relationship between the percentage ﬂuorescence chromatic
response (%FCR, see Materials and methods) and HDL concentration
conﬁrms that the chromatic changes in the vesicles indeed corre-
spond to binding of the HDL particles to the vesicles.
Fig. 2 depicts a bar diagram comparing the ﬂuorescence response
induced by the different lipoproteins following their incubation with
DMPC/PDA vesicles and DMPE/DMPG/PDA vesicles, respectively. The
particular phospholipid compositions shown in Fig. 2 include
phospholipids present in cellular membranes, exhibiting head groups
with different sizes and electrostatic charges. It should be emphasized
that the data presented in Fig. 2 encompass several experiments
carried out at different days and utilizing pooled lipoproteins
harvested from all patients underlining the experimental signiﬁcance
of the observed variances among the chromatic responses. Indeed, the
Fig. 2. Fluorescence of lipid/PDA vesicles induced by lipoproteins. Fluorescence of DMPC/PDA vesicles (white bars) and DMPE/DMPG/PDA vesicles (dark bars) following addition of
(A) LDL; (B) HDL. (i) Lipoproteins harvested fromhealthy controls; (ii) lipoproteins fromdiabetic patients; (iii) lipoproteins oxidized in vitro. Excitationwas 544 nm, emission 620 nm.
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afﬁnities of the lipoproteins examined to membrane bilayers.
Fig. 2 highlights several important trends. First, differences in
chromatic response induced by the lipoproteins were apparent betw-
een the two vesicle lipid compositions employed (DMPC compared to
DMPE/DMPG). This result underscores the dependence of lipoprotein
binding to the bilayer upon themolecular properties of the lipids, such
as the size of the headgroupor its electrostatic charge. Fig. 2 also points
to generally higher ﬂuorescence signals induced by LDL (Fig. 2A)
compared to HDL (Fig. 2B), which can most likely be traced to the
lower surface density and bigger size of the LDL particles [22].
Comparable to the results presented in Fig. 1, the bar diagram in
Fig. 2 also demonstrates that experimentally signiﬁcant differences in
lipid binding occurred between lipoproteins extracted from healthy
controls vs. diabetic patients and between native and oxidized
lipoproteins. For example, LDL isolated from sera of healthy controls
induced a %FCR of approximately 70% when added to DMPE/DMPG/
PDA vesicles (Fig. 2Ai, dark bars); the ﬂuorescence chromatic
response was reduced to less than 40% for LDL harvested from
diabetic patients (Fig. 2Aii, dark bars) and around 30% in case of oxi-
dized LDL (Fig. 2Aiii, dark bars).
Higher chromatic signals from lipoproteins extracted from healthy
controls were observed also in case of HDL (Fig. 2B), particularly when
HDL was incubated with DMPE/DMPG/PDA vesicles (Fig. 2B, dark
bars), but also in case of DMPC/PDA vesicles (Fig. 2B, white bars).
Beside the differences between vesicles interactions of healthy vs.
diabetic-extracted lipoproteins, Fig. 2 points to a higher chromatic
response induced by native lipoproteins vs. lipoproteins oxidized in
vitro. This trend was universal—occurring in both vesicle composi-
tions and for both HDL and LDL. A non-parametric version of one-way
ANOVA test was performed (Kruskal–Wallis) on all data sets to
conﬁrm the statistical signiﬁcance of the observed variations in Fig. 2
The p-values obtained were all under the threshold of p=0.05
(except in the case of LDL added to DMPC/PDA vesicles where
p= 0.09). Indeed, this was the only result in which no apparent
difference was observed between the lipoproteins extracted from
healthy and diabetic patients, respectively). Thus, the ANOVA test
results indicate that the differences in the chromatic data presented in
Fig. 2 are experimentally signiﬁcant.
3.2. Polymer-labeled cell assay
To gain insight into lipoprotein binding to actual cellular plasma
membranes (rather than biomimetic chromatic vesicles, summarized
in Figs. 1 and 2), we analyzed lipoprotein/membrane interactions
using a recently developed PDA-labeled live cell assay [13,15]. The
PDA-labeled cells platform illuminates binding to the plasma
membrane of living cells by amphiphilic or hydrophobic molecules
through monitoring the ﬂuorescent emission of PDA patches fused to
the cell surface [13].Fig. 3 depicts confocal ﬂuorescence and bright ﬁeld microscopy
images of PDA-labeled J-774 macrophage cells incubated with
different HDL samples. The control PDA-labeled cells (prior to
addition of the lipoproteins, Fig. 3A) exhibit scattered low-ﬂuores-
cence regions since the PDA patches fused to the cell membrane were
in the initial polymerized phase [13]. However, signiﬁcantly enhanced
ﬂuorescent domains localized within the cell surfaces appeared
following incubation of the PDA-labeled cells with HDL isolated
from healthy controls (Fig. 3B). The pronounced ﬂuorescence is due to
the structurally transformed PDA, most likely affected by perturba-
tions to the plasma membrane induced by binding of the HDL
particles.
In contrast to the marked ﬂuorescence induced by membrane
interactions with native HDL particles (Fig. 3B), incubation of the
PDA-labeled cells with HDL extracted from diabetic patients yielded
much reduced ﬂuorescence emission (Fig. 3C). This result is ascribed
to lesser membrane binding of the diabetes-affected HDL particles
and is consistent with the chromatic vesicle results presented in
Figs. 1 and 2. Similarly insigniﬁcant ﬂuorescence induction of
membrane-embedded PDA was observed when oxidized HDL
particles were incubated with the cells (Fig. 3D). Furthermore,
similar differences of ﬂuorescence induction were also observed in
case of LDL particles (data not shown), conﬁrming the observation
that signiﬁcant modulation of membrane interactions occur upon
using lipoproteins harvested from diabetic patients compared to
healthy controls.
3.3. Biophysical and microscopy analyses
The results presented in Figs. 1–3 using the chromatic vesicles and
cell assays both point to signiﬁcant membrane disruption by
lipoproteins and particularly differences between membrane binding
of lipoproteins harvested from diabetic patients and following
lipoprotein oxidation, as compared to healthy controls. In order to
corroborate the results and interpretation of the chromatic assay
analysis, we carried out experiments utilizing complementary
biophysical techniques (Figs. 4 and 5).
Fig. 4 depicts the results of a ﬂuorescence resonance energy
transfer (FRET) experiment employing DMPE/DMPG vesicles that also
incorporated the ﬂuorophores N-(7-nitro-2,1,3-benzoxadiazol-4-yl)-
phosphatidylethanolamine (N-NBD-PE, ﬂuorescence donor) and
N-(lissamine rhodamine B sulfonyl) phosphatidylethanolamine (N-
Rh-PE, ﬂuorescence acceptor) [23]. FRET experiments have been
widely used tomonitormembrane fusion and bilayer interactions [23].
Initially, efﬁcient ﬂuorescence energy transfer occurs between the
donor and acceptor within the vesicles containing the two ﬂuoro-
phores (which are in close proximity). However, when bilayer
perturbation and/or fusion of the ﬂuorophore-containing vesicles
with other (un-labeled) particles takes place, the extent of ﬂuores-
cence energy transfer is reduced [23].
Fig. 3. Microscopy experiments utilizing PDA-labeled macrophages. (A) Control; (B) addition of HDL from healthy controls; (C) addition of HDL from diabetic patients; and (D)
addition of oxidized HDL.
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energy transfer following incubation of the NBD-PE/Rh-PE/DMPE/
DMPG with different lipoproteins. In general, FRET disruption
appeared more pronounced when the vesicles were incubated with
LDL particles (Fig. 4A) compared to HDL (Fig. 4B) (higher percentage
corresponds to greater bilayer disruption, seeMaterials andmethods).
This observation echoes the lower chromatic signals recorded after
incubating the lipid/PDA vesicles with HDL compared to LDL (Fig. 2)
andmost likely reﬂects the lesser propensity of themore compact HDL
to bind and insert into lipid bilayers.
Fig. 4 further illustrates that disease-affected or oxidized lipopro-
teins exhibited lesser effects upon the recorded FRET values compared
to the lipoproteins harvested from healthy controls. For example, LDL
harvested from serum of healthy controls resulted in almost 40% FRET
decrease (Fig. 4Ai), while the corresponding values following
incubation of the NBD-PE/Rh-PE/DMPE/DMPG vesicles with diabetic
LDL (Fig. 4Aii) andwith oxidized LDL particles (Fig. 4Aiii) were around
25% and 35%, respectively. Similar modulation of the FRET results wasFig. 4. FRET analysis of NBD-PE/Rh-PE/DMPE/DMPG vesicles treated with lipoproteins. Gra
100%, see Materials and methods). (A) LDL; (B) HDL. In both graphs: (i) lipoproteins harvest
lipoproteins.observed for HDL (Fig. 4B). Overall, the FRET results summarized in
Fig. 4 are fully consistent with the chromatic data in Figs. 1–3, which
pointed to signiﬁcantly lower membrane binding of LDL and HDL
isolated from diabetic patients or oxidized. A non-parametric version
of one-way ANOVA test was performed (Kruskal–Wallis) on all data
sets, producing p-values that were lower than 0.05, conﬁrming the
statistical signiﬁcance of the differences in the FRET values recorded in
Fig. 4.
Fig. 5 depicts the results of ﬂuorescence quenching experiments
utilizing NBD-PE/DMPE/DMPG vesicles. The experiments summa-
rized in Fig. 5 record the modulation of the ﬂuorescence quenching of
NBD by sodium dithionite added to the vesicle solution. Quenching of
the NBD-PE dye, which is embedded within the lipid bilayers, is
generally affected by binding of membrane-active species, such as the
lipoproteins in this study [24].
Similar to the chromatic data (Figs. 1–3) and FRET analysis (Fig. 4),
the quenching data in Fig. 5 demonstrate that signiﬁcant differences
occurred between the bilayer binding proﬁles of lipoproteinsph showing decrease of FRET, relative to triton (the effect of the detergent is deﬁned as
ed from healthy controls; (ii) lipoproteins isolated from diabetic patients; (iii) oxidized
Fig. 5.Modulation of the ﬂuorescence quenching of bilayer-embedded NBD-PE by lipoproteins. Dithionite-induced ﬂuorescence quenching curves of NBD-PE/DMPG/DMPE vesicles
pre-incubated with: (A) LDL; (B) HDL. (i) Control vesicles (no lipoproteins added); (ii) vesicles pre-incubated with lipoproteins from healthy controls; (iii) vesicles pre-incubated
with lipoproteins from diabetic patients; (iv) vesicles pre-incubated with oxidized lipoproteins.
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lipoproteins harvested from diabetic patients or oxidized lipoproteins,
on the other hand. This discrepancy was apparent both in case of LDL
(Fig. 5A), as well as HDL (Fig. 5B), although some differences were
observed between the two lipoprotein classes.
Speciﬁcally, in the case of LDL (Fig. 5A), the slower quenching rate
recorded after pre-incubation of the NBD-PE/DMPE/DMPG vesicles
with particles from the healthy controls is indicative of tight bindingFig. 6. Cryo-TEM of DMPC vesicles treated with LDL. (A) Control DMPC vesicles (not treate
vesicles incubated with LDL isolated from diabetic patients; (D) DMPC vesicles incubated wof the lipoproteins onto the vesicle surface, which consequently partly
shields the NBD dye from the soluble dithionite quencher [24]. This
interpretation is consistent with the chromatic vesicle data; previous
studies have correlated pronounced chromatic responses to tight
binding to lipid bilayer surfaces [25]. Fig. 5A further shows that LDL
from diabetic patients or oxidized LDL both yielded faster ﬂuorescence
quenching in comparison with the native LDL, signifying lesser
binding at the vesicle surface. Indeed, in case of LDL, the quenchingd); (B) DMPC vesicles incubated with LDL harvested from healthy controls; (C) DMPC
ith oxidized LDL. Bar corresponds to 100 nm.
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curves iii and iv) appear close to the rate recorded for control vesicles
(Fig. 5A, curve i).
Quenching experiments utilizing HDL particles (Fig. 5B) similarly
displayed signiﬁcantly faster rates of lipoproteins harvested from
diabetic patients or oxidized compared to normal particles. In the case
of HDL, however, the quenching curves of the particles harvested from
diabetic patients (Fig. 5A, curve iii) or oxidized particles (Fig. 5B, curve
iv) were in fact lower than the control vesicles for which no
lipoproteins were added (Fig. 5B, curve i). This effect is ascribed to
insertion of the HDL particles (which are smaller andmore condensed
than the LDL particles) into the lipid bilayers, exposing the NBD dye to
the soluble dithionite [24] and thus facilitating more rapid quenching
than the control vesicles.
To examine whether distinct membrane interactions of the
lipoproteins can be also discerned through microscopy, we examined
DMPC vesicles incubated with different LDL specimens using
cryogenic-transmission electron microscopy (cryo-TEM; Fig. 6).
While cryo-TEM has been previously used for analysis of LDL
microstructures [26,27], Fig. 6 examines the effect of the LDL particles
upon the phospholipid vesicles. The electron micrographs in Fig. 6
demonstrate that LDL particles exert signiﬁcant structural effects
upon DMPC unilamellar vesicles, and moreover there exist pro-
nounced differences between the structural effects upon the vesicles
by native LDL compared to diabetic or oxidized LDL.
Fig. 6B shows that incubation of the DMPC vesicles with native LDL
resulted in swelling of the vesicles, combined with apparent
encapsulation of smaller vesicles. The modiﬁed multilamellar vesic-
ular structures are most likely induced through binding of the LDL
particles to the lipid vesicles (the individual LDL particles can beFig. 7. Cryo-TEM of DMPC vesicles treated with HDL. (A) Control DMPC vesicles (not treate
vesicles incubated with HDL isolated from diabetic patients. Bar corresponds to 100 nm.discerned as the darker particulates at the grid interface; Fig. 6B,
bottom image). Signiﬁcantly different vesicular structures, however,
were observed following incubation of DMPC with LDL harvested
from diabetic patients (Fig. 6C) or following incubation with oxidized
LDL (Fig. 6D). The cryo-TEM images in Figs. 6C and D reveal slightly
distorted unilamellar vesicles punctuated on one side with darker
aggregates. We speculate that the opaque assemblies attached to the
lipid vesicles depicted in Fig. 6C correspond to aggregates of the small
LDL particles; lower abundance of LDL particles was indeed observed
in the cryo-TEM analysis of the diabetic and oxidized LDL samples
compared to the native LDL.
Cryo-TEM experiments examining the interactions of HDL
particles and DMPC vesicles similarly revealed intriguing differences
between normal or abnormal HDL (Fig. 7). While HDL obtained from
healthy individuals yielded somewhat swollen and distorted DMPC
vesicles (Fig. 7B; the individual non-reacted HDL particulates can be
discerned at the grid interface), HDL isolated from diabetic patients
gave rise to noticeably smaller DMPC vesicles encapsulating
contracted disk-like structures, which might correspond to distorted
vesicle-internalized HDL particles (Fig. 7C). The differences in the
cryo-TEM results between the effects of HDL (Fig. 7) and LDL (Fig. 6)
are consistent with the chromatic and biophysical data discussed
above and most likely reﬂect the distinct sizes and molecular
organization of the two particle species, which affect their
membrane interactions.
4. Discussion
Cholesterol trafﬁcking (inﬂux/efﬂux) following interactions of
lipoproteinswith speciﬁcmembrane-localized receptors is consideredd); (B) DMPC vesicles incubated with HDL harvested from healthy controls; (C) DMPC
2443N. Hanin-Avraham et al. / Biochimica et Biophysica Acta 1788 (2009) 2436–2443a crucial effector in the progression of varied coronary diseases and has
by far garnered the most scientiﬁc, biomedical and pharmaceutical
interest. Here we show that non-speciﬁc membrane binding of
lipoproteins are signiﬁcantly modulated in lipoproteins affected by
oxidative stress. In particular, we demonstrate that modulation of
membrane binding of lipoproteins can be exploited as a powerful
marker for oxidative stress using recently developed simple chromatic
vesicle and cell assays.
The experiments depicted in Figs. 1 and 2 demonstrated that
dramatic differences in chromatic responses were induced by
lipoproteins isolated from diabetic patients and by lipoproteins
oxidized in vitro compared to native lipoproteins. These differences
were clearly apparent both in case of LDL, as well as HDL, and indicate
that the abnormal lipoproteins exhibited less afﬁnity to membrane
bilayers compared to the native particles. The effects were observed in
different vesicle compositions (vesicles comprising DMPC and
vesicles containing DMPE/DMPG, Fig. 2) pointing to the generality
of this phenomenon. Importantly, signiﬁcant differences in mem-
brane interactions were also recorded in the context of the actual
plasma membrane, probed through application of the PDA-labeled
live cell assay (Fig. 3).
Application of biophysical characterization techniques corrobo-
rated the chromatic assay data and further highlighted the modula-
tion of membrane binding of lipoproteins in situations of oxidative
stress. Speciﬁcally, FRET analysis (Fig. 4) pointed to less signiﬁcant
bilayer disruption by diabetic or oxidized lipoproteins compared to
physiologically normal particles. Fluorescence quenching experi-
ments (Fig. 5) suggest that diabetes or lipoprotein oxidation reduced
binding of LDL or HDL at the bilayer/water interface. Electron
microscopy images (Fig. 6) underscored the dramatic structural
effects of lipoproteins upon vesicle bilayers and the distinctly different
effects induced by normal vs. disease-extracted particles.
Overall, this investigation suggests that disease conditions,
particularly lipid oxidation, have insidious effects upon membrane
interactions of lipoproteins. In particular, this work suggests that
membrane–lipoprotein interactions, exposed through application of
the newly developed chromatic vesicle and cell assays, might
constitute a novel marker for lipoprotein abnormalities. This work
points to the potential use of the biomimetic chromatic assays as
platforms for rapid detection of oxidative stress-related disease and
for screening the effectiveness of therapeutic treatments. In particu-
lar, we foresee the development of rapid screening tests, based upon
the chromatic vesicle assay, which would either utilize isolated
lipoprotein specimens or even complete sera, for detecting adverse
oxidative stress conditions.
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